Projects per year
Abstract
The small ubiquitin-like modifier (SUMO) protease SENP6 disassembles SUMO chains from cellular substrate proteins. We use a proteomic method to identify putative SENP6 substrates based on increased apparent molecular weight after SENP6 depletion. Proteins of the lamin family of intermediate filaments show substantially increased SUMO modification after SENP6 depletion. This is accompanied by nuclear structural changes remarkably like those associated with laminopathies. Two SUMO attachment sites on lamin A/C are close to sites of mutations in Emery-Driefuss and limb girdle muscular dystrophy. To establish a direct link between lamin SUMOylation and the observed phenotype, we developed proximity-induced SUMO modification (PISM), which fuses a lamin A/C targeting DARPin to a SUMO E3 ligase domain. This directly targets lamin A/C for SUMO conjugation and demonstrates that enhanced lamin SUMO modification recapitulates the altered nuclear structure manifest after SENP6 depletion. This shows SENP6 activity protects the nucleus against hyperSUMOylation-induced laminopathy-like alterations.
Original language | English |
---|---|
Article number | 112960 |
Number of pages | 32 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 8 |
Early online date | 8 Aug 2023 |
DOIs | |
Publication status | Published - 29 Aug 2023 |
Keywords
- CP: Cell biology
- CP: Molecular biology
- PISM
- SENP6
- SUMO
- lamin
- laminopathy
- nuclear blebbing
- proteomics
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'SUMO protease SENP6 protects the nucleus from hyperSUMOylation-induced laminopathy-like alterations'. Together they form a unique fingerprint.-
Establishing the Basis for Selectivity in the SUMO Spray (Investigator Award)
Hay, R. (Investigator)
1/02/20 → 31/01/27
Project: Research
-
Training Network in Drug Discovery Targeting TRIM Ubiquitin Ligases in Disease (TRIM-NET) (Joint with University of Trieste as lead; CNRS; Karlsruhe Institute of Technology; Leiden University Medical Centre; French National Institute for Agricultural Research; Casa Sollievo della Sofferenza Hospital, Italy; CSIC; Netherlands Cancer Institute)
Hay, R. (Investigator)
COMMISSION OF THE EUROPEAN COMMUNITIES
1/01/19 → 30/06/23
Project: Research
-
Harnessing the PML-SUMO-RNF4 Axis for Cancer Therapy (Programme Grant)
Hay, R. (Investigator)
1/12/16 → 30/09/22
Project: Research